http://medicalxpress.com/ en-us Medical Xpress internet news portal provides the latest news on Health and Medicine. (Medical Xpress) -- Reduced mobility among patients with secondary‐progressive multiple sclerosis (SPMS) is associated with a decline in quality of life, according to new data presented today at the 7th World Congress of NeuroRehabilitation in Melbourne. http://medicalxpress.com/news/2012-05-mobility-key-quality-life-ms.html Diseases, Conditions, Syndromes Fri, 18 May 2012 08:30:30 EST news256548609 (HealthDay) -- Doctors and patients need to be aware of the potential risk of injuries and death associated with an experimental treatment for multiple sclerosis called liberation therapy, the U.S. Food and Drug Administration said in an alert issued Thursday. http://medicalxpress.com/news/2012-05-fda-issues-controversial-ms-treatment.html Diseases, Conditions, Syndromes Thu, 10 May 2012 17:10:01 EST news255884974 (Medical Xpress) -- The progression of the debilitating disease Multiple Sclerosis (MS) could be slowed or even halted by blocking a protein that contributes to nerve damage, according to a new study. http://medicalxpress.com/news/2012-04-scientists-handbrake-ms.html Neuroscience Thu, 26 Apr 2012 09:15:34 EST news254650487 An investigational oral drug called ONO-4641 reduced the number of lesions in people with multiple sclerosis (MS), according to the results of a phase two clinical trial to be presented as Emerging Science (formerly known as Late-Breaking Science) at the American Academy of Neurology's 64th Annual Meeting in New Orleans April 21 to April 28, 2012. http://medicalxpress.com/news/2012-04-ono-pill-ms-lesions-phase.html Neuroscience Mon, 16 Apr 2012 16:00:03 EST news253810569 Patients with relapsing onset Multiple Sclerosis (MS) who consumed alcohol, wine, coffee and fish on a regular basis took four to seven years longer to reach the point where they needed a walking aid than people who never consumed them. However the study, published in the April issue of the European Journal of Neurology, did not observe the same patterns in patients with progressive onset MS. http://medicalxpress.com/news/2012-03-lifestyle-highlights-key-differences-relapsing.html Neuroscience Mon, 19 Mar 2012 10:30:01 EST news251370320 (HealthDay) -- Male veterans with multiple sclerosis (MS) have an increased prevalence of chronic diseases compared with the general population and with veterans without MS, according to a study published online Feb. 9 in the U.S. Centers for Disease Control and Prevention's Preventing Chronic Disease. http://medicalxpress.com/news/2012-03-vets-ms-higher-prevalence-chronic.html Diseases, Conditions, Syndromes Sat, 17 Mar 2012 06:12:19 EST news251183523 (HealthDay) -- Yet another orally taken medication shows some promise in preventing relapse and disability for people with relapsing-remitting multiple sclerosis, a new report suggests. http://medicalxpress.com/news/2012-03-experimental-pill-ease-multiple-sclerosis.html Diseases, Conditions, Syndromes Wed, 14 Mar 2012 18:21:03 EST news250968055 Warm weather may hinder cognitive performance in people with multiple sclerosis (MS), according to results of a Kessler Foundation study e-published online ahead of print by Neurology. An accompanying editorial by Meier & Christodoulou, MS and heat: The smoke and the fire, details the study's unique aspects, ie, longitudinal followup in a cohort with apparently quiescent disease. http://medicalxpress.com/news/2012-03-ms-documents-negative-effect-warmer.html Neuroscience Tue, 13 Mar 2012 14:08:32 EST news250866421 Women who have multiple pregnancies may have a lower risk of developing multiple sclerosis (MS), according to research published in the March 7, 2012, online issue of Neurology, the medical journal of the American Academy of Neurology. http://medicalxpress.com/news/2012-03-pregnancies-linked-ms-women.html Neuroscience Wed, 07 Mar 2012 16:03:00 EST news250358540 In a new study published in the March issue of Radiology, functional magnetic resonance imaging (fMRI) shows that cognitive rehabilitation changes brain function and improves cognitive performance in patients with relapsing-remitting multiple sclerosis (MS). http://medicalxpress.com/news/2012-02-cognitive-brain-patients-ms.html Inflammatory disorders Wed, 22 Feb 2012 04:54:59 EST news249108876 Multiple sclerosis (MS), a neurodegenerative disease, causes periodic attacks of neurologic symptoms such as limb weakness and mobility defects. And while MS patients' walking abilities and muscle strength are examined on a regular basis, doctors have yet to determine when the lower limb muscles begin to deteriorate. That's important because with earlier identification of mobility problems, doctors would be able to implement early intervention programs that could make all the difference for those with MS. http://medicalxpress.com/news/2012-01-muscling-multiple-sclerosis.html Medical research Thu, 26 Jan 2012 10:11:38 EST news246795087 Neuroscientists at Kessler Foundation have documented increased cerebral activation in patients with multiple sclerosis (MS) following memory retraining using the modified Story Memory Technique (mSMT). http://medicalxpress.com/news/2012-01-greater-brain-cognitive-ms.html Neuroscience Tue, 17 Jan 2012 14:26:52 EST news246032319 A new study from researchers at Queen Mary, University of London shows how a particular virus tricks the immune system into triggering inflammation and nerve cell damage in the brain, which is known to cause MS. http://medicalxpress.com/news/2012-01-link-virus-ms-treatment.html Neuroscience Thu, 05 Jan 2012 10:20:01 EST news244980542 Medical researchers at the University of Alberta have discovered a new way to track the progression of multiple sclerosis (MS) in those living with the disease, by using a powerful, triple strength MRI to track increasing levels of iron found in brain tissue. http://medicalxpress.com/news/2011-12-powerful-mri-track-iron-brain.html Neuroscience Thu, 15 Dec 2011 13:27:46 EST news243178058 Multiple sclerosis (MS) may progress from the outermost layers of the brain to its deep parts, and isn't always an "inside-out" process as previously thought, reported a new collaborative study from researchers at the Mayo Clinic and the Cleveland Clinic. The traditional understanding is that the disease begins in the white matter that forms the bulk of the brain's inside, and extends to involve the brain's superficial layers, the cortex. Study findings support an opposite, outside-in process: from the cerebrospinal fluid-filled subarachnoid space, that cushions the outside of the brain and the cortex, into the white matter. The new findings will guide researchers as they seek to further understand and treat the disease. The study was published in the December issue of the New England Journal of Medicine. http://medicalxpress.com/news/2011-12-multiple-sclerosis-brain-outer-layers.html Medical research Wed, 07 Dec 2011 17:00:11 EST news242497574 The first study to investigate risk factors for the vascular condition called CCSVI (chronic cerebrospinal venous insufficiency) in volunteers without neurological disease has identified what the researchers call a remarkable similarity between this condition and possible or confirmed risk factors for multiple sclerosis (MS). http://medicalxpress.com/news/2011-11-factors-ccsvi-similar-ms.html Neuroscience Wed, 30 Nov 2011 17:58:47 EST news241898304 Low vitamin D levels are associated with an increased risk of developing multiple sclerosis (MS), but the first randomized, controlled trial using high-dose vitamin D in MS did not find any added benefit over and above ongoing low-dose vitamin D supplementation, according to a study published in the October 25, 2011, issue of Neurology, the medical journal of the American Academy of Neurology. http://medicalxpress.com/news/2011-10-high-dose-vitamin-d-low-dose-ms.html Neuroscience Mon, 24 Oct 2011 16:33:29 EST news238692784 A new oral drug has been shown in a large international clinical trial to significantly reduce the relapse rate of people with multiple sclerosis and to slow the progression of the disease. http://medicalxpress.com/news/2011-10-oral-drug-relapses-multiple-sclerosis.html Medications Thu, 06 Oct 2011 10:22:22 EST news237115307 Taking the new generation anti-inflammatory drug natalizumab for two years lowers the number of remitting multiple sclerosis patients who experience relapses and progression of disability. This is the main finding of a systematic review published in the latest edition of The Cochrane Library. http://medicalxpress.com/news/2011-10-remitting-multiple-sclerosis-natalizumab-relapses.html Diseases, Conditions, Syndromes Wed, 05 Oct 2011 04:18:58 EST news237007118 A new study examining the cost-effectiveness of drugs to treat multiple sclerosis (MS) in the United States finds that the health gains from these drugs come at a very high cost compared to basic therapy to control the symptoms of MS and compared to treatments for other chronic diseases. The research is published in the July 20, 2011, online issue of Neurology, the medical journal of the American Academy of Neurology. http://medicalxpress.com/news/2011-07-ms-drugs-high.html Neuroscience Wed, 20 Jul 2011 16:41:20 EST news230398869 Canadian researchers have found that maternal multiple sclerosis (MS) is generally not associated with adverse delivery outcomes or risk to their offspring. Full findings now appear in Annals of Neurology, a journal published by Wiley-Blackwell on behalf of the American Neurological Association. http://medicalxpress.com/news/2011-06-pregnancy-safe-multiple-sclerosis.html Neuroscience Mon, 27 Jun 2011 03:29:51 EST news228364174 (Medical Xpress) -- Multiple sclerosis (MS) appears to be associated with loss of bone mineral density, but that loss may not be due to lack of weight-bearing activity, the usual cause of osteoporosis. http://medicalxpress.com/news/2011-05-ms-bone-loss-brain-inflammation.html Neuroscience Wed, 25 May 2011 05:37:07 EST news225520597 New studies released in the April issue of the Journal of Correctional Health Care (JCHC) (published by SAGE) are helping the California Department of Corrections and Rehabilitation (CDCR) to establish a set of prison health care quality measurements. http://medicalxpress.com/news/2011-05-california-department-yields-quality.html Health Mon, 16 May 2011 12:38:04 EST news224768216 (Medical Xpress) -- In addition to the health problems children with multiple sclerosis face, a risk of obesity has entered the picture. A new study conducted by pediatric MS specialists at the University at Buffalo has found that children with multiple sclerosis and other pediatric demyelinating disorders are at increased risk of childhood obesity, compared to children without these disorders. http://medicalxpress.com/news/2011-05-children-ms-obese-childhood.html Health Thu, 12 May 2011 06:46:22 EST news224401536 Disease-modifying drugs (DMDs) are injected medications used to slow the progression of multiple sclerosis (MS), and have been shown to reduce the frequency and severity of relapses. But according to a new study led by St. Michael's Hospital and the Institute for Clinical Evaluative Sciences (ICES), adherence to all DMDs is low, with less than half of patients, or 44 per cent, continually adherent after two years. http://medicalxpress.com/news/2011-05-patients-ms-adhere-drug-therapies.html Diseases, Conditions, Syndromes Tue, 10 May 2011 13:19:16 EST news224252341 (Medical Xpress) -- Pregnancy appears to have a positive effect on long-term disability in women with two types of multiple sclerosis, indicating that reproductive hormones may play a protective role in MS progression, neurology researchers at the University at Buffalo have found. http://medicalxpress.com/news/2011-05-pregnancy-women-ms-mitigate.html Diseases, Conditions, Syndromes Wed, 04 May 2011 09:21:42 EST news223719669 Many patients with progressive multiple sclerosis (MS) worry how quickly the disease will progress. Now, by noting the presence of certain markers in a commonly performed diagnostic test, Mayo Clinic researchers can predict whether patients will suffer a faster onset of disability and counsel them to help ease anxiety. The research is being presented at the American Academy of Neurology meeting in Honolulu, Hawaii. http://medicalxpress.com/news/2011-04-mayo-clinic-tool-disability-timeline.html Medical research Tue, 12 Apr 2011 10:51:25 EST news221824270